Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is -20.60% vs 9.79% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is -8.93% vs 9,375.82% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is -11.23% vs -18.09% in Mar 2025
Compare Balance Sheet Results of Jagsonpal Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.39
53.15
-39.76
-74.81%
Share Warrants & Outstandings
Total Reserve
242.30
156.62
85.68
54.71%
Shareholder's Funds
276.17
209.77
66.40
31.65%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
2.48
-2.48
-100.00%
Secured Loans
0.00
2.48
-2.48
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
4.44
3.68
0.76
20.65%
Other Long Term Liabilities
6.59
0.00
6.59
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.18
0.37
0.81
218.92%
Total Non-Current Liabilities
12.21
6.52
5.69
87.27%
Current Liabilities
Trade Payables
11.58
39.42
-27.84
-70.62%
Other Current Liabilities
15.39
17.76
-2.37
-13.34%
Short Term Borrowings
0.00
43.12
-43.12
-100.00%
Short Term Provisions
1.32
0.61
0.71
116.39%
Total Current Liabilities
28.30
100.91
-72.61
-71.96%
Total Liabilities
316.68
317.20
-0.52
-0.16%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
93.62
54.59
39.03
71.50%
Less: Accumulated Depreciation
15.09
14.23
0.86
6.04%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
78.53
40.36
38.17
94.57%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
10.17
-10.17
-100.00%
Long Term Loans & Advances
0.65
6.62
-5.97
-90.18%
Other Non Current Assets
87.63
0.33
87.30
26,454.55%
Total Non-Current Assets
173.59
57.47
116.12
202.05%
Current Assets Loans & Advances
Current Investments
0.00
0.01
-0.01
-100.00%
Inventories
14.64
75.59
-60.95
-80.63%
Sundry Debtors
17.19
104.17
-86.98
-83.50%
Cash and Bank
106.12
3.41
102.71
3,012.02%
Other Current Assets
1.66
1.60
0.06
3.75%
Short Term Loans and Advances
3.47
74.95
-71.48
-95.37%
Total Current Assets
143.09
259.73
-116.64
-44.91%
Net Current Assets (Including Current Investments)
114.79
158.82
-44.03
-27.72%
Total Current Assets Excluding Current Investments
143.09
259.72
-116.63
-44.91%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
316.68
317.20
-0.52
-0.16%
Contingent Liabilities
22.34
0.25
22.09
8,836.00%
Total Debt
0.00
45.60
-45.60
-100.00%
Book Value per share (adjusted)
41.01
3.95
37.06
938.23%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 6.59 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -20.60% vs 9.79% in Mar 2025
Annual - Fixed Assets
Fixed Assets 78.53 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -8.93% vs 9,375.82% in Mar 2025
Annual - Investments
Investments 0.00 Cr
in Mar 2026Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 143.09 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -11.23% vs -18.09% in Mar 2025
Footer loading
